- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.03 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 01: 1-[7-[3-fluoranyl-4-(trifluoromethyl)phenoxy]-3,4-dihydro-1~{H}-isoquinolin-2-yl]propan-1-one
01.1: 20 residues within 4Å:- Chain A: F.14, A.16, F.32, V.33, A.83, L.85, V.99, T.115, V.117, K.127, M.149, C.150, M.153, F.156, I.157, L.160, L.173, F.176, I.178, F.198
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.14, A:F.32, A:V.99, A:T.115, A:V.117, A:K.127, A:I.178, A:F.198
- Hydrogen bonds: A:C.150
01.13: 19 residues within 4Å:- Chain B: F.14, A.16, F.32, V.33, A.83, L.85, V.99, T.115, V.117, M.149, C.150, M.153, F.156, I.157, L.160, L.173, F.176, I.178, F.198
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:F.14, B:F.14, B:A.16, B:F.32, B:V.99, B:T.115, B:V.117, B:I.178, B:F.198
- Hydrogen bonds: B:C.150
01.24: 18 residues within 4Å:- Chain C: F.14, A.16, F.32, A.83, L.85, V.99, T.115, V.117, M.149, C.150, M.153, F.156, I.157, L.160, L.173, F.176, I.178, F.198
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:F.14, C:F.14, C:F.32, C:V.99, C:T.115, C:V.117, C:I.178, C:F.198
- Hydrogen bonds: C:C.150
01.37: 19 residues within 4Å:- Chain D: F.14, A.16, F.32, V.33, A.83, L.85, V.99, T.115, V.117, M.149, C.150, M.153, F.156, I.157, L.160, L.173, F.176, I.178, F.198
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:F.14, D:F.14, D:A.16, D:F.32, D:V.99, D:T.115, D:V.117, D:I.157, D:I.178, D:F.198
- Hydrogen bonds: D:C.150
- 23 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: G.71, P.72, Q.73
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.73
SO4.4: 3 residues within 4Å:- Chain A: S.119, V.124, Y.152
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.119, A:S.119, A:Y.152
SO4.6: 4 residues within 4Å:- Chain A: K.127, C.150, E.151
- Chain B: R.185
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:E.151, B:R.185
- Water bridges: A:K.127, A:K.127, A:Y.152
- Salt bridges: A:K.127
SO4.10: 4 residues within 4Å:- Chain A: H.34, I.35, G.36, H.209
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:H.34, A:G.36
- Salt bridges: A:H.34, A:H.209
SO4.17: 6 residues within 4Å:- Chain B: H.34, I.35, G.36, H.38, H.209
- Chain C: G.138
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:G.36
- Salt bridges: B:H.34, B:H.38, B:H.209
SO4.18: 3 residues within 4Å:- Chain B: G.71, P.72, Q.73
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.73
- Water bridges: B:G.71, B:N.74
SO4.19: 2 residues within 4Å:- Chain B: C.150, E.151
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.151
SO4.28: 5 residues within 4Å:- Chain C: H.34, I.35, G.36, H.38, H.209
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:G.36
- Water bridges: C:H.209, C:H.209, C:H.209
- Salt bridges: C:H.34, C:H.38, C:H.209
SO4.29: 3 residues within 4Å:- Chain C: G.71, P.72, Q.73
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:Q.73
- Water bridges: C:Q.73, C:N.74
SO4.30: 4 residues within 4Å:- Chain C: C.150, E.151
- Chain D: Y.132, R.185
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain D- Hydrogen bonds: C:E.151
- Salt bridges: D:R.185
SO4.41: 5 residues within 4Å:- Chain A: G.138
- Chain D: H.34, I.35, G.36, H.209
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:G.36
- Salt bridges: D:H.34, D:H.209
SO4.42: 3 residues within 4Å:- Chain D: G.71, P.72, Q.73
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.73
- Water bridges: D:N.74
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.20: 4 residues within 4Å:- Chain B: L.163, M.168, S.171, V.172
2 PLIP interactions:2 interactions with chain B- Water bridges: B:S.171, B:N.175
PEG.40: 5 residues within 4Å:- Chain C: R.134, N.145, R.146
- Chain D: R.134, N.145
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain D- Hydrogen bonds: C:R.134, C:N.145, C:R.146, D:R.134, D:N.145
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Aplin, A.E., Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models. To Be Published
- Release Date
- 2025-07-30
- Peptides
- Transcriptional enhancer factor TEF-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBBC
CCCD
DDD
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.03 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 01: 1-[7-[3-fluoranyl-4-(trifluoromethyl)phenoxy]-3,4-dihydro-1~{H}-isoquinolin-2-yl]propan-1-one
- 23 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Aplin, A.E., Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models. To Be Published
- Release Date
- 2025-07-30
- Peptides
- Transcriptional enhancer factor TEF-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBBC
CCCD
DDD